New York, NY, United States of America

Declan Gwynne

USPTO Granted Patents = 1 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Declan Gwynne

Introduction

Declan Gwynne is an accomplished inventor based in New York, NY. He has made significant strides in the field of drug delivery systems, showcasing his expertise through his innovative patent. His work is characterized by a commitment to improving healthcare solutions.

Latest Patents

Gwynne holds a patent for a drug delivery device designed for administration to a subject. This device features a reservoir containing an active pharmaceutical ingredient and a potential energy source. It includes a trigger that is operatively associated with the potential energy source, which is configured to actuate at a predetermined location within the subject. Additionally, the device has a rupturable membrane along a flow path extending between the reservoir and an outlet. This membrane is designed to rupture when the trigger is actuated, allowing the potential energy to expel the active pharmaceutical ingredient in a jet through the outlet.

Career Highlights

Throughout his career, Declan Gwynne has worked with prestigious organizations, including the Massachusetts Institute of Technology and Novo Nordisk A/S. His experiences in these institutions have contributed to his development as an inventor and have provided him with a platform to innovate in the pharmaceutical field.

Collaborations

Gwynne has collaborated with notable individuals in his field, including Graham Arrick and Torben Sebastian Last. These partnerships have likely enhanced his research and development efforts, leading to advancements in drug delivery technologies.

Conclusion

Declan Gwynne's contributions to the field of drug delivery devices exemplify his innovative spirit and dedication to improving healthcare solutions. His patent reflects a significant advancement in the administration of pharmaceuticals, showcasing the potential for future developments in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…